Evaluation of environmental contaminations and occupational exposures involved in preparation of chemotherapeutic drugs

Yakugaku Zasshi

Volumn 130, Issue 6, 2010, Pages 903-910

  Maeda, Shinichiro ^a   Miyawaki, Koji ^a   Matsumoto, Shoji ^a   Oishi, Masako ^a   Miwa, Yoshihiro ^a   Kurokawa, Nobuo ^a  

^a OSAKA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Cyclophosphamide; Environmental contamination; Liquid chromatography mass spectrometry mass spectrometry; Occupational exposure; Solid phase extraction

Indexed keywords

ANTIINFECTIVE AGENT; CYCLOPHOSPHAMIDE;

ARTICLE; CONTAMINATION; ENVIRONMENTAL EXPOSURE; HOSPITAL PATIENT; HUMAN; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; NURSE; OCCUPATIONAL EXPOSURE; OUTPATIENT CARE; PHARMACIST; URINALYSIS; URINARY EXCRETION;

ANTINEOPLASTIC AGENTS; CHROMATOGRAPHY, LIQUID; CYCLOPHOSPHAMIDE; ENVIRONMENTAL EXPOSURE; HEALTH FACILITY ENVIRONMENT; HOSPITALS; HUMANS; IFOSFAMIDE; NURSES; OCCUPATIONAL EXPOSURE; PHARMACISTS; PHARMACY; TANDEM MASS SPECTROMETRY;

EID: 77953146119     PISSN: 00316903     EISSN: 13475231     Source Type: Journal    
DOI: 10.1248/yakushi.130.903     Document Type: Article

References (48)

1. Falck K., Grohn P., Sorsa M., Vainio H., Heinonen E., Holsti L. R., Lancet, 1, 1250-1251 (1979).
2. Roth S., Norppa H., Jarventaus H., Kyyronen P., Ahonen M., Lehtomaki J., Sainio H., Sorsa M., Mutat. Res., 325, 157-162 (1994).
3. Jakab M. G., Major J., Tompa A., J. Toxicol. Environ. Health A, 62, 307-318 (2001).
4. Kasuba V., Rozgaj R., Garaj-Vrhovac V., J. Appl. Toxicol., 19, 401-404 (1999).
5. Lanza A., Robustelli della Cuna F. S., Zibera C., Pedrazzoli P., Robustelli della Cuna G., Int. Arch. Occup. Environ. Health, 72, 315-322 (1999).
6. Burgaz S., Karahalil B., Bayrak P., Taskin L., Yavuzaslan F., Bokesoy I., Anzion R. B., Bos R. P., Platin N., Mutat. Res., 439, 97-104 (1999).
7. Kopjar N., Garaj-Vrhovac V., Mutagenesis, 16, 71-78 (2001).
8. Sessink P. J., Kroese E. D., van Kranen H. J., Bos R. P., Int. Arch. Occup. Environ. Health, 67, 317-323 (1995).
9. Sessink P. J., Boer K. A., Scheefhals A. P., Anzion R. B., Bos R. P., Int. Arch. Occup. Environ. Health., 64, 105-112 (1992).
10. Hirst M., Tse S., Mills D. G., Levin L., White D. F., Lancet, 1, 186-188 (1984).
11. Ensslin A. S., Stoll Y., Pethran A., Pfaller A., Rommelt H., Fruhmann G., Occup. Environ. Med., 51, 229-233 (1994).
12. Sessink P. J., Van de Kerkhof M. C., Anzion R. B., Noordhoek J., Bos R. P., Arch. Environ. Health, 49, 165-169 (1994).
13. Minoia C., Turci R., Sottani C., Schiavi A., Perbellini L., Angeleri S., Draicchio F., Apostoli P., Rapid Commun. Mass Spectrom., 12, 1485-1493 (1998).
14. Pethran A., Schierl R., Hauff K., Grimm C. H., Boos K. S., Nowak D., Int. Arch. Occup. Environ. Health, 76, 5-10 (2003).
15. Ikeda K., Yagi Y., Takegami M., Lu Y., Morimoto K., Kurokawa N., Hospital pharmacy (Philadelphia, PA), 42, 209-218 (2007).
16. Connor T. H., Shults M., Fraser M. P., Mutat. Res., 470, 85-92 (2000).
17. "Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans: Some Antineoplastic and Immunosuppressive Agents, Cyclophosphamide," International Agency for Research on Cancer, Lyon, 1981.
18. Sottani C., Turci R., Schierl R., Gaggeri R., Barbieri A., Violante F. S., Minoia C., Rapid Commun. Mass Spectrom., 21, 1289-1296 (2007).
19. Larson R. R., Khazaeli M. B., Dillon H. K., Am. J. Health Syst. Pharm., 59, 270-277 (2002).
20. Tomioka K., Kumagai S., Sangyo Eiseigaku Zasshi, 47, 195-203 (2005).
21. Burgaz S., Karahalil B., Canhi Z., Terzioglu F., Ancel G., Anzion R. B., Bos R. P., Huttner E., Hum. Exp. Toxicol., 21, 129-135 (2002).
22. Sabatini L., Barbieri A., Tosi M., Violante F. S., J. Mass Spectrom., 40, 669-674 (2005).
23. Hedmer M., Tinnerberg H., Axmon A., Jonsson B. A., Int. Arch. Occup. Environ. Health, 81, 899-911 (2008).
24. McCarroll N., Keshava N., Cimino M., Chu M., Dearfield K., Keshava C., Kligerman A., Owen R., Protzel A., Putzrath R., Schoeny R., McCarroll N., Keshava N., Cimino M., Chu M., Dearfield K., Keshava C., Kligerman A., Owen R., Protzel A., Putzrath R., Schoeny R., Environ. Mol. Mutagen., 49, 117-131 (2008).
25. Anderson D., Bishop J. B., Garner R. C., Ostrosky-Wegman P., Selby P. B., Mutat. Res., 330, 115-181 (1995).
26. Turci R., Sottani C., Ronchi A., Minoia C., Toxicol. Lett., 134, 57-64 (2002).
27. Barbieri A., Sabatini L., Indiveri P., Bonfiglioli R., Lodi V., Violante F. S., Rapid Commun. Mass Spectrom., 20, 1889-1893 (2006).
28. Perico A., Lorini C., Biliotti T., Bavazzano P., Lanciotti E., Ann Ig, 15, 363-371 (2003).
29. Fransman W., Vermeulen R., Kromhout H., Int. Arch. Occup. Environ. Health, 78, 403-412 (2005).
30. Nabeshima T. S., Toru., Sugiura S., Tanimura M., Nakao M., Nakanishi H., Kato K., J. Jpn. Soc. Hosp. Pharm., 44, 18-20 (2008).
31. "Guideline for Aseptic Preparation of Injectable and Antineoplastic Drugs," ed. by Japanese Society of Hospital Pharmacists, Yakuji Nippo Ltd., Tokyo, 2008.
32. Mochizuki C., Fujikawa I., Tei G., Yoshida J., J. Jpn. Soc. Hosp. Pharm., 44, 601-604 (2008).
33. Touzin K., Bussieres J. F., Langlois E., Lefebvre M., J. Oncol. Pharm. Pract., 15, 53-61 (2009).
34. Sessink P. J., van den Broek P. H., Bos R. P., J. Appl. Toxicol., 11, 125-128 (1991).
35. Sottani C., Rinaldi P., Leoni E., Poggi G., Teragni C., Delmonte A., Minoia C., Rapid Commun. Mass Spectrom., 22, 2645-2659 (2008).
36. Nishigaki R., Konno E., Sugiyasu M., Yoneyama M., Otsuka T., Watanabe Y., Gunji T., Totsuka Y., Wakabayashi K., Endo K., Yamamoto H., J. Jpn. Soc. Hosp. Pharm., 46, 113-117 (2010).
37. Chambers E., Wagrowski-Diehl D. M., Lu Z., Mazzeo J. R., J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 852, 22-34 (2007).
38. Yoshida J., Tei G., Mochizuki C., Masu Y., Koda S., Kumagai S., Ann. Occup. Hyg., 53, 153-160 (2009).
39. Lijinsky W., Carcinogenesis, 14, 2373-2375 (1993).
40. Joqueviel C., Martino R., Gilard V., Malet-Martino M., Canal P., Niemeyer U., Drug Metab. Dispos., 26, 418-428 (1998).
41. Hedmer M., Hoglund P., Cavallin-Stahl E., Albin M., Jonsson B. A., Int. Arch. Occup. Environ. Health, 81, 285-293 (2008).
42. Bailey H., Mulcahy R. T., Tutsch K. D., Rozental J. M., Alberti D., Arzoomanian R. Z., Tombes M. B., Trump D. L., Wilding G., Cancer Res., 51, 1099-1104 (1991).
43. Hadidi A. H., Coulter C. E., Idle J. R., Cancer Res., 48, 5167-5171 (1988).
44. Boddy A. V., Furtun Y., Sardas S., Sardas O., Idle J. R., J. Natl. Cancer. Inst., 84, 1744-1748 (1992).
45. McDevitt J. J., Lees P. S., McDiarmid M. A., J. Occup. Med., 35, 57-60 (1993).
46. Yabunaka H., Matsuda Y., Sakaguchi F., Furuya Y., Tanino T., Abstract of papers, the 129th Annual Meeting of the Pharmaceutical Society of Japan, Kyoto, March 2009, No. 4, p. 236.
47. Fransman W., Vermeulen R., Kromhout H., Ann. Occup. Hyg., 48, 237-244 (2004).
48. Sorsa M., Anderson D., Mutat. Res., 355, 253-261 (1996).